Jürgen Bulitta

Has grant

Professor and Perry E. Foote Eminent Scholar Chair

University of Florida

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Combating resistant superbugs by understanding the molecular determinants of target site penetration and binding

Open Date: 2018-08-01

Close Date: 2023-07-01

Grant: Close

Next-generation combination dosing strategies to combat resistant Acinetobacter baumannii

Open Date: 2017-11-01

Close Date: 2022-10-01

Grant: Close

Study to Investigate the Sensitivity of Pharmacokinetics in Detecting Differences in Physicochemical Properties of the Active in Suspension Nasal Products for Local Action

Open Date: 2017-09-01

Close Date: 2018-09-01

Grant: Close

A Preclinical Mouse Model of Acinetobacter baumannii Infection For Antibacterial Development

Open Date: 2017-09-01

Close Date: 2020-09-01

Grant: Close

Combating resistant Gram-negative bacterial superbugs via omics techniques

Open Date: 2017-06-01

Close Date: 2019-05-01

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (5)

Jessica Tait

MONASH UNIVERSITY

AUSTRALIA

View details

Eunjeong Shin

Case Western Reserve University

UNITED STATES

View details

Miranda J. Wallace

Washington University in St. Louis

UNITED STATES

View details

Yinzhi Lang

Research Asst. Professor

University of Florida

UNITED STATES

View details

Ashley N. Brown

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jürgen Bulitta

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula

Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens

Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance

Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology

Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model

Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling

Why Molnupiravir Fails in Hospitalized Patients

Synthesis and Structure–Activity Relationship of Thioacetamide-Triazoles against Escherichia coli

Combination Regimens of Favipiravir Plus Interferon Alpha Inhibit Chikungunya Virus Replication in Clinically Relevant Human Cell Lines

FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development

Collaborators (5)

Jessica Tait

Eunjeong Shin

Miranda J. Wallace

Yinzhi Lang

Ashley N. Brown

Make your next move.